Non-synergy of PD-1 blockade with T-cell therapy in solid tumors.
Saved in:
| Title: | Non-synergy of PD-1 blockade with T-cell therapy in solid tumors. |
|---|---|
| Authors: | Davies JS; NCI, National Institutes of Health, Bethesda, Maryland, USA.; Safety Assessment, Genentech Inc, South San Francisco, California, USA., Karimipour F; NCI, National Institutes of Health, Bethesda, Maryland, USA., Zhang L; NCI, National Institutes of Health, Bethesda, Maryland, USA., Nagarsheth N; NCI, National Institutes of Health, Bethesda, Maryland, USA., Norberg S; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Serna C; NCI, National Institutes of Health, Bethesda, Maryland, USA.; Immuno-Oncology Translational Medicine, AstraZeneca Gaithersburg, Gaithersburg, Maryland, USA., Strauss J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Chiou S; Cancer Immunotherapy, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Gulley JL; NCI, National Institutes of Health, Bethesda, Maryland, USA., Hinrichs CS; Cancer Immunotherapy, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA ch977@cinj.rutgers.edu. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jul; Vol. 10 (7). |
| Publication Type: | Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
